Meditoxin 200UI

Meditoxin 200UI, an immunobiological agent possessing muscle-relaxing properties, comprises a protein complex sourced from Clostridium botulinum. Within normal physiological processes, this complex undergoes breakdown, releasing pure neurotoxin. Meditoxin type A binds to motor neuron nerve endings, infiltrating nerve cells and inhibiting acetylcholine release at the neuromuscular synapse. Consequently, localized muscle denervation occurs chemically, inducing muscle weakness and paralysis.

Description

Meditoxin, a type A botulinum toxin developed by Medytox Inc., is renowned for its exceptional quality and safety standards.

Even in young women, wrinkles can emerge from active facial expressions. With time, these wrinkles become more pronounced, making them challenging to manage. Meditoxin targets the root cause of wrinkles: strained or overly active facial muscles. By inducing relaxation, it smooths wrinkles, leveraging the skin’s elastic properties. The effects typically last 4-6 months.

Advantages of Meditoxin:

• Rapid onset: Noticeable results can be seen as early as the 2nd day post-procedure, with full effect achieved by day 10.
• Long-lasting efficacy
• Targeted action
• High patient satisfaction rates

Indications:

• Treatment of essential blepharospasm in individuals aged 18 and above
• Management of equinus foot deformity caused by spasticity in children with cerebral palsy aged 2 and above
• Correction of deep glabellar (frown line) wrinkles in adults under 65